Lupus nephritis Trials in Seoul, South Korea
Conditions / Lupus nephritis / Seoul, South Korea
Research into Lupus nephritis spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03943147 | An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis | TERMINATED | PHASE2 |
| NCT04181762 | Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis | TERMINATED | PHASE3 |
| NCT05126277 | Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis | RECRUITING | PHASE3 |
| NCT00089804 | Study of LJP 394 in Lupus Patients With History of Renal Disease | TERMINATED | PHASE3 |
| NCT06581198 | A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) | RECRUITING | PHASE2 |
| NCT01714817 | Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis | TERMINATED | PHASE3 |
| NCT04564339 | Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) | TERMINATED | PHASE2 |
| NCT03021499 | Aurinia Renal Response in Active Lupus With Voclosporin | COMPLETED | PHASE3 |
| NCT01639339 | Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis | COMPLETED | PHASE3 |
| NCT02547922 | Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis | COMPLETED | PHASE2 |